BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7646822)

  • 1. Which drugs affect potassium?
    Howes LG
    Drug Saf; 1995 Apr; 12(4):240-4. PubMed ID: 7646822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE inhibitors and diuretics causing hypokalaemia.
    D'Costa DF; Basu SK; Gunasekera NP
    Br J Clin Pract; 1990 Jan; 44(1):26-7. PubMed ID: 2317435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors associated with a high velocity of the development of hyperkalaemia in hospitalised patients.
    Indermitte J; Burkolter S; Drewe J; Krähenbühl S; Hersberger KE
    Drug Saf; 2007; 30(1):71-80. PubMed ID: 17194172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypokalaemia in the elderly: is it always diuretic-induced?
    Nasar MA; Lyle EM
    Br J Clin Pract; 1994; 48(1):19-21. PubMed ID: 8179975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperkalemias].
    Radó J; Haris A
    Orv Hetil; 1999 Nov; 140(47):2611-8. PubMed ID: 10613044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the concomitant use of angiotensin-converting enzyme inhibitors, non-steroidal anti-inflammatory drugs and diuretics.
    Bucsa C; Moga DC; Farcas A; Mogosan C; Dumitrascu DL
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2938-44. PubMed ID: 26241552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic adverse reactions to diuretics. Clinical relevance to elderly patients.
    Baglin A; Boulard JC; Hanslik T; Prinseau J
    Drug Saf; 1995 Mar; 12(3):161-7. PubMed ID: 7619328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study.
    Fournier JP; Lapeyre-Mestre M; Sommet A; Dupouy J; Poutrain JC; Montastruc JL
    PLoS One; 2012; 7(3):e34187. PubMed ID: 22479557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction.
    Ray K; Dorman S; Watson R
    J Hum Hypertens; 1999 Oct; 13(10):717-20. PubMed ID: 10516744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced abnormalities of potassium metabolism.
    Kokot F; Hyla-Klekot L
    Pol Arch Med Wewn; 2008; 118(7-8):431-4. PubMed ID: 18714739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extreme hyperkalaemia caused by concomitant use of a NSAID and an ace inhibitor in an elderly patient.
    Rogulj D; Hauptfeld M; Iskra MS; Zorko VK; Strasek M
    Arh Hig Rada Toksikol; 2010 Jun; 61(2):241-5. PubMed ID: 20587399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life-threatening hyperkalaemia caused by angiotensin-converting enzyme-inhibitor and diuretics.
    Odawara M; Asano M; Yamashita K
    Diabet Med; 1997 Feb; 14(2):169-70. PubMed ID: 9047098
    [No Abstract]   [Full Text] [Related]  

  • 15. Diuretic complications.
    Greenberg A
    Am J Med Sci; 2000 Jan; 319(1):10-24. PubMed ID: 10653441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disorders of hypo- and hyperkalemia.
    Kunau RT; Stein JH
    Clin Nephrol; 1977 Apr; 7(4):173-90. PubMed ID: 322901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA
    Cardiovasc Ther; 2012 Jun; 30(3):e156-66. PubMed ID: 21883995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperkalemia during prolonged use of angiotensin II-converting enzyme inhibitors in end-stage renal insufficiency].
    Mooser V; Fellay G; Regamey C
    Schweiz Med Wochenschr; 1992 Dec; 122(50):1927-9. PubMed ID: 1465596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Potassium Homeostasis in CKD.
    DuBose TD
    Adv Chronic Kidney Dis; 2017 Sep; 24(5):305-314. PubMed ID: 29031357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs.
    Bugge JF
    J Intern Med; 1996 Oct; 240(4):249-51. PubMed ID: 8918517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.